Autoimmune hepatitis natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Autoimmune Disease]] | |||
[[Category:Needs overview]] | [[Category:Needs overview]] |
Revision as of 18:34, 27 February 2013
Autoimmune hepatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Autoimmune hepatitis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Autoimmune hepatitis natural history, complications and prognosis |
FDA on Autoimmune hepatitis natural history, complications and prognosis |
CDC on Autoimmune hepatitis natural history, complications and prognosis |
Autoimmune hepatitis natural history, complications and prognosis in the news |
Blogs on Autoimmune hepatitis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Prognosis
- The prognosis is generally thought to be inversely correlated with the histologic severity of disease.
- Approximately 50% of patients will remain in remission or have only mild disease when steroids are withdrawn after the initial therapy.
- Most patients, however, will require long-term maintenance therapy.